Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 126

    1.

    Differential sensitivity to central leptin and insulin in male and female rats.

    Clegg DJ, Riedy CA, Smith KA, Benoit SC, Woods SC.

    Diabetes. 2003 Mar;52(3):682-7.PMID: 12606509 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Melanocortin receptors mediate leptin effects on feeding and body weight but not adipose apoptosis.

    Choi YH, Li C, Page K, Westby A, Della-Fera MA, Lin J, Hartzell DL, Baile CA.

    Physiol Behav. 2003 Sep;79(4-5):795-801.PMID: 12954425 [PubMed - indexed for MEDLINE]Related articles

    3.

    The catabolic action of insulin in the brain is mediated by melanocortins.

    Benoit SC, Air EL, Coolen LM, Strauss R, Jackman A, Clegg DJ, Seeley RJ, Woods SC.

    J Neurosci. 2002 Oct 15;22(20):9048-52.PMID: 12388611 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Effects of acute and chronic administration of the melanocortin agonist MTII in mice with diet-induced obesity.

    Pierroz DD, Ziotopoulou M, Ungsunan L, Moschos S, Flier JS, Mantzoros CS.

    Diabetes. 2002 May;51(5):1337-45.PMID: 11978628 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Differential role of melanocortins in mediating leptin's central effects on feeding and reproduction.

    Hohmann JG, Teal TH, Clifton DK, Davis J, Hruby VJ, Han G, Steiner RA.

    Am J Physiol Regul Integr Comp Physiol. 2000 Jan;278(1):R50-9.PMID: 10644621 [PubMed - indexed for MEDLINE]Related articles

    6.

    Central melanocortin receptor agonist reduces spontaneous and scheduled meal size but does not augment duodenal preload-induced feeding inhibition.

    Azzara AV, Sokolnicki JP, Schwartz GJ.

    Physiol Behav. 2002 Nov;77(2-3):411-6.PMID: 12419417 [PubMed - indexed for MEDLINE]Related articles

    7.

    Increased dietary fat attenuates the anorexic effects of intracerebroventricular injections of MTII.

    Clegg DJ, Benoit SC, Air EL, Jackman A, Tso P, D'Alessio D, Woods SC, Seeley RJ.

    Endocrinology. 2003 Jul;144(7):2941-6.PMID: 12810549 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The hypothalamic paraventricular nucleus is not essential for orexigenic NPY or anorexigenic melanocortin action.

    Dube MG, Kalra SP, Kalra PS.

    Peptides. 2006 Sep;27(9):2239-48. Epub 2006 Jun 8.PMID: 16759748 [PubMed - indexed for MEDLINE]Related articles

    9.

    Role of melanocortin-4 receptors in mediating renal sympathoactivation to leptin and insulin.

    Rahmouni K, Haynes WG, Morgan DA, Mark AL.

    J Neurosci. 2003 Jul 9;23(14):5998-6004.PMID: 12853417 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Reduced anorexigenic efficacy of leptin, but not of the melanocortin receptor agonist melanotan-II, predicts diet-induced obesity in rats.

    van Dijk G, de Vries K, Nyakas C, Buwalda B, Adage T, Kuipers F, Kas MJ, Adan RA, Wilkinson CW, Thiele TE, Scheurink AJ.

    Endocrinology. 2005 Dec;146(12):5247-56. Epub 2005 Sep 15.PMID: 16166222 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Insulin and leptin combine additively to reduce food intake and body weight in rats.

    Air EL, Benoit SC, Clegg DJ, Seeley RJ, Woods SC.

    Endocrinology. 2002 Jun;143(6):2449-52.PMID: 12021212 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Leptin-induced leptin resistant rats exhibit enhanced responses to the melanocortin agonist MT II.

    Scarpace PJ, Matheny M, Zolotukhin S, Tümer N, Zhang Y.

    Neuropharmacology. 2003 Aug;45(2):211-9.PMID: 12842127 [PubMed - indexed for MEDLINE]Related articles

    13.

    Central infusion of melanocortin agonist MTII in rats: assessment of c-Fos expression and taste aversion.

    Thiele TE, van Dijk G, Yagaloff KA, Fisher SL, Schwartz M, Burn P, Seeley RJ.

    Am J Physiol. 1998 Jan;274(1 Pt 2):R248-54.PMID: 9458925 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Adrenalectomy alters the sensitivity of the central nervous system melanocortin system.

    Drazen DL, Wortman MD, Schwartz MW, Clegg DJ, van Dijk G, Woods SC, Seeley RJ.

    Diabetes. 2003 Dec;52(12):2928-34.PMID: 14633853 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Feeding, body weight, and sensitivity to non-ingestive reward stimuli during and after 12-day continuous central infusions of melanocortin receptor ligands.

    Cabeza de Vaca S, Hao J, Afroz T, Krahne LL, Carr KD.

    Peptides. 2005 Nov;26(11):2314-21.PMID: 15894406 [PubMed - indexed for MEDLINE]Related articles

    16.

    Feeding responses to a melanocortin agonist and antagonist in obesity induced by a palatable high-fat diet.

    Hansen MJ, Schiöth HB, Morris MJ.

    Brain Res. 2005 Mar 28;1039(1-2):137-45.PMID: 15781055 [PubMed - indexed for MEDLINE]Related articles

    17.

    CNS melanocortin and leptin effects on stearoyl-CoA desaturase-1 and resistin expression.

    Lin J, Choi YH, Hartzell DL, Li C, Della-Fera MA, Baile CA.

    Biochem Biophys Res Commun. 2003 Nov 14;311(2):324-8.PMID: 14592417 [PubMed - indexed for MEDLINE]Related articles

    18.

    Anorexic but not pyrogenic actions of interleukin-1 are modulated by central melanocortin-3/4 receptors in the rat.

    Lawrence CB, Rothwell NJ.

    J Neuroendocrinol. 2001 Jun;13(6):490-5.PMID: 11412335 [PubMed - indexed for MEDLINE]Related articles

    19.

    Aged-obese rats exhibit robust responses to a melanocortin agonist and antagonist despite leptin resistance.

    Zhang Y, Matheny M, Tümer N, Scarpace PJ.

    Neurobiol Aging. 2004 Nov-Dec;25(10):1349-60.PMID: 15465633 [PubMed - indexed for MEDLINE]Related articles

    20.

    Modulation of the satiating effect of amylin by central ghrelin, leptin and insulin.

    Osto M, Wielinga PY, Alder B, Walser N, Lutz TA.

    Physiol Behav. 2007 Aug 15;91(5):566-72. Epub 2007 Mar 30.PMID: 17481674 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data